Quarterly report pursuant to Section 13 or 15(d)

Organization and Summary of Significant Accounting Policies (Tables)

v3.22.2.2
Organization and Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Mar. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments The following presents a reconciliation of the impacted financial statement line items as previously reported to the restated amounts as of March 31, 2022 and December 31, 2021, and for the three months ended March 31, 2022 and 2021:
March 31, 2022 December 31, 2021
Condensed Consolidated Balance Sheets As Previously Reported Restatement Adjustment As Restated As Previously Reported Restatement Adjustment As Restated
Deferred revenue 42,757  21,697  64,454  43,345  19,094  62,439 
Total current liabilities 160,107  21,697  181,804  133,958  19,094  153,052 
Total liabilities 193,376  21,697  215,073  276,436  19,094  295,530 
Accumulated deficit (1,151,689) (21,697) (1,173,386) (1,162,040) (19,094) (1,181,134)
Total stockholders' equity 373,673  (21,697) 351,976  320,825  (19,094) 301,731 

Three Months Ended March 31, 2022 Three Months Ended March 31, 2021
Condensed Consolidated Statements of Operations As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Revenues:
Sharing 33,577  (2,603) 30,974  21,649  (1,423) 20,226 
Total revenues 37,978  (2,603) 35,375  25,670  (1,423) 24,247 
Total gross margin 3,423  (2,603) 820  2,040  (1,423) 617 
General and administrative 84,650  —  84,650  30,190  (811) 29,379 
Total operating expenses 100,214  —  100,214  40,996  (811) 40,185 
Loss from operations (96,791) (2,603) (99,394) (38,956) (612) (39,568)
Income (loss) before income taxes 10,388  (2,603) 7,785  (76,180) (612) (76,792)
Net income (loss) 10,351  (2,603) 7,748  (76,200) (612) (76,812)
Earnings (loss) per share attributable to common stockholders, basic and diluted 0.04  (0.01) 0.03  (1.69) (0.01) (1.70)

Three Months Ended March 31, 2022 Three Months Ended March 31, 2021
Consolidated Statements of Comprehensive Loss As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Net income (loss) 10,351  (2,603) 7,748  (76,200) (612) (76,812)
Total comprehensive loss, net of tax 5,878  (2,603) 3,275  (78,525) (612) (79,137)
Three Months Ended March 31, 2022 Three Months Ended March 31, 2021
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Net income (loss) 10,351  (2,603) 7,748  (76,200) (612) (76,812)
Accumulated other comprehensive income 3,065  —  3,065  10,680  (3,312) 7,368 
Accumulated deficit (1,151,689) (21,697) (1,173,386) (1,041,907) (1,115) (1,043,022)
Total stockholders' equity 373,673  (21,697) 351,976  (938,683) (4,427) (943,110)

Three Months Ended March 31, 2022 Three Months Ended March 31, 2021
Condensed Consolidated Statements of Cash Flow As Previously Reported Restatement Adjustment Restated As Previously Reported Restatement Adjustment Restated
Net income (loss) 10,351  (2,603) 7,748  (76,200) (612) (76,812)
Changes in assets and liabilities:
Deferred revenue (474) 2,603  2,129  1,378  1,423  2,801 
Accrued expenses and other current liabilities 3,952  —  3,952  (1,459) (811) (2,270)
Net cash used in operating activities (42,565) —  (42,565) (36,337) —  (36,337)